Evidence map›Paper›PMID 30305775›Full record

ArticleJournal of medical physics

Dosimetry of

Navideh Aghaei-Amirkhizi, Sodeh Sadjadi, Leila Moghaddam-Banaem, Mitra Athari-Allaf, Fariba Johari-Deha

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Navideh Aghaei-AmirkhiziDepartment of Medical Radiation Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Sodeh SadjadiDepartment of Production and Separation of Isotopes, Nuclear Material and Fuel School, Nuclear Science and Technology Research Institute, Tehran, Iran.
Leila Moghaddam-BanaemDepartment of Production and Separation of Isotopes, Nuclear Material and Fuel School, Nuclear Science and Technology Research Institute, Tehran, Iran.
Mitra Athari-AllafDepartment of Medical Radiation Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Fariba Johari-DehaDepartment of Radiopharmacy and Radioisotopes Research, Applied of Radiation School, Nuclear Science and Technology Research Institute, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis investigation focuses on biodistribution of irradiated dendrimer encapsulated ytterbium-175 (

methodsA dendrimer compound containing an average of 55 Yb

resultsThe specific activity and radiochemical purity of the irradiated nano-composite were 7MBq/mg and >99% respectively. The rapid up take of dendrimer was in liver, lung, and, spleen. MIRD and MCNPX were applied for dose estimation. The human absorbed dose in liver, lung, spleen, kidney and bone that simulated by MCNP are 1.266, 0.8081, 0.8347, 0.03979 and 0.01706 mGy/MBq respectively and these values for MIRD schema are 1.351, 0.73, 1.03, 0.039, and 0.0097 mGy/MBq respectively.

conclusionThe results showed that

Indexed as

dosimetryMCNPmedical internal radiation dosimetrynano-radiopharmaceuticalpoly (amidoamine)Ytterbium-175

Identifiers

PMID30305775
PMCPMC6172863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.